Risk stratification, recommended thromboprophylaxis and optimal duration of prophylaxis by patient group.
Patient groups . | Recommended thromboprophylaxis options* . | Optimal duration of prophylaxis . |
---|---|---|
*The recommended options may differ somewhat for specific patient groups based on available evidence. See the 8th ACCP Guidelines on the Prevention of VTE.1 | ||
GCS indicates graduated compression stocking; PCD, pneumatic compression device, VFP, venous foot pump. | ||
Low VTE Risk: | ||
|
| Not applicable. |
Moderate VTE Risk: | ||
|
| Continue until discharge for the majority of patients. Selected patients may benefit from post-discharge prophylaxis. |
High VTE Risk: | ||
|
| Minimum of 10 days and up to 35 days. |
High VTE Risk: | ||
|
| Continue until discharge for the majority of patients. Prophylaxis should be continued for the inpatient rehabilitation period. |
High bleeding risk | ||
| Duration appropriate for the specific patient risk group. |
Patient groups . | Recommended thromboprophylaxis options* . | Optimal duration of prophylaxis . |
---|---|---|
*The recommended options may differ somewhat for specific patient groups based on available evidence. See the 8th ACCP Guidelines on the Prevention of VTE.1 | ||
GCS indicates graduated compression stocking; PCD, pneumatic compression device, VFP, venous foot pump. | ||
Low VTE Risk: | ||
|
| Not applicable. |
Moderate VTE Risk: | ||
|
| Continue until discharge for the majority of patients. Selected patients may benefit from post-discharge prophylaxis. |
High VTE Risk: | ||
|
| Minimum of 10 days and up to 35 days. |
High VTE Risk: | ||
|
| Continue until discharge for the majority of patients. Prophylaxis should be continued for the inpatient rehabilitation period. |
High bleeding risk | ||
| Duration appropriate for the specific patient risk group. |